Akums Drugs and Pharmaceuticals Ltd
BSE: 544222
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 392.27+15.9% | 338.37-8.2% | 368.61+19.2% | 309.31-7.0% | 332.44+1.1% | 328.75-2.6% | 337.41+2.8% | 328.35 |
| Other Income | 26.10-5.9% | 27.73-6.3% | 29.60+9.3% | 27.08-5.2% | 28.55-10.9% | 32.05-5.3% | 33.84+5.3% | 32.12 |
| Total Income | 418.38+14.3% | 366.10-8.1% | 398.21+18.4% | 336.39-6.8% | 361.00+0.1% | 360.80-2.8% | 371.25+3.0% | 360.47 |
| EXPENSES | ||||||||
| Expenditure | 359.04+5.1% | 341.60-4.7% | 358.54+17.5% | 305.19+1.2% | 301.49-6.9% | 323.75+2.3% | 316.36+5.9% | 298.85 |
| Tax | 14.50+119.9% | 6.59-14.9% | 7.75+0.2% | 7.74-47.1% | 14.64+54.6% | 9.47-31.0% | 13.72+21.9% | 11.25 |
| PROFIT | ||||||||
| PBT | 59.34+172.3% | 21.79-39.2% | 35.87+15.0% | 31.20-47.6% | 59.51+60.6% | 37.05-32.5% | 54.89-10.9% | 61.62 |
| Net Profit | 44.84+195.1% | 15.20-45.9% | 28.11+19.8% | 23.46-47.7% | 44.87+62.6% | 27.59-33.0% | 41.17-18.3% | 50.37 |
| KEY METRICS | ||||||||
| OPM % | 12.36%+9.68pp | 2.68%-2.98pp | 5.66%+0.20pp | 5.46%-7.81pp | 13.27%+7.88pp | 5.39%+3.00pp | 2.39%-2.46pp | 4.85% |
| NPM % | 10.72%+6.57pp | 4.15%-2.91pp | 7.06%+0.09pp | 6.97%-5.46pp | 12.43%+4.78pp | 7.65%-3.44pp | 11.09%-2.88pp | 13.97% |
| EPS | 2.93+196.0% | 0.99-46.2% | 1.84+20.3% | 1.53-47.8% | 2.93+62.8% | 1.80-33.1% | 2.69-20.4% | 3.38 |
Corporate Events
Board MeetingAKUMS
20268Aug
Board Meeting
The meeting of the Board of Directors is scheduled to consid…
BSE Filing ↗ Board MeetingAKUMS
202623Jul
Board Meeting
The Board Meeting was held on July 23, 2026, to consider and…
BSE Filing ↗ Board MeetingAKUMS
202610Jul
Board Meeting
The 22nd Annual General Meeting will be held to receive, con…
BSE Filing ↗ Board MeetingAKUMS
20249Nov
Board Meeting
Consider and approve the Un-audited (Standalone & Consolidat…
BSE Filing ↗ Board MeetingAKUMS
202424Aug
Board Meeting
Consider and approve the Un-audited (Standalone & Consolidat…
BSE Filing ↗